Regulation of human natural killer-cell lytic activity by serine/threonine phosphatases and kinases.
D002460:Cell Line; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004988:Ethers, Cyclic / Q000494:pharmacology; D006706:Homeostasis; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000201:enzymology* / Q000276:immunology*; D007700:Kinetics; D008223:Lymphoma; D008387:Marine Toxins; D019319:Okadaic Acid; D010080:Oxazoles / Q000494:pharmacology; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013953:Thymus Neoplasms; D014407:Tumor Cells, Cultured
D004791:Enzyme Inhibitors; D004988:Ethers, Cyclic; D008387:Marine Toxins; D010080:Oxazoles; D019319:Okadaic Acid; C059041:calyculin A; D017346:Protein Serine-Threonine Kinases; D017027:Protein Tyrosine Phosphatases